The Technology Surrounding Decentralized Clinical Trials
How heavily do decentralized clinical trials rely on technology? We asked Craig Lipset, a leading expert in the field of decentralized clinical trials.
Jun
2023
Jun
2023
Boosting Oncology Care with Decentralized Clinical Trials
Discover how Decentralized Clinical Trials (DCTs) have the potential to reshape oncology care. Using our eyesON DCT Outlook, we reveal how patient demographics, broadband internet, and registered oncologists could drive DCT opportunities and potentially enhance cancer survivorship.
May
2023
eyesON | Decentralized Clinical Trials Outlook: USA
Data visualization tool designed to identify untapped opportunities for Decentralized Clinical Trials advancement in the oncology sector in the USA.
May
2023
Training Implications of the ICH E6(R3) and E8(R1) Guidelines
Be prepared for ICH E6(R3): turn guidelines into real-world action. In this post, we delve into the key updates and training gaps.
May
2023
A Comparative Review of the ICH E6(R3) and E8(R1) Guidelines
Unpacking the new ICH guidelines, E6(R3) and E8(R1), we illuminate their key elements, identify gaps, and compare the two in terms of their unity, differences, and complementarity.
May
2023
Embracing the Future: FDA’s New Draft Guidance on Decentralized Clinical Trials
Dive into the FDA's latest draft guidance on Decentralized Clinical Trials and the role of Risk-Based Quality Management. Learn how RBQM and centralized monitoring can elevate your clinical research efficiency and reliability.
May
2023
Big Pharma M&As: Is It Worth the Trouble?
Big Pharma M&As: A Worthwhile Challenge? Navigating the complex landscape of M&As in the pharmaceutical industry comes with unique objectives and potential benefits. But do these transactions truly drive shareholder value for the acquiring firm?
May
2023
Enhancing R&D Due Diligence in Pharma M&As: The Role of MyRBQM Portal
Navigate your M&A journey confidently with Cyntegrity's MyRBQM Portal. Aspiring to hit your targets within 6-12 months? Discover how we can make it possible in R&D due diligence.
Apr
2023
eyesON | Big Pharma M&As: Clinical Trials Data Visualization
Users can explore the impact of M&As on pharma companies, by examining how it affects their number of ran clinical trials, R&D spending, and share prices.
Apr
2023
Global Impact of COVID-19 Pandemic on Clinical Trials
Wondering how the COVID-19 pandemic has impacted clinical trials worldwide? The COVID-19 pandemic has brought unprecedented challenges to the healthcare industry worldwide. The clinical trial sector has been no exception, and it has undergone significant changes over the past few years. From the [...]